Supriya Lifescience - Quaterly Results

28 Oct 2024 Evaluate
A fair growth of 18.56% in the revenue at Rs. 1661.02 millions was reported in the September 2024 quarter as compared to Rs. 1400.95 millions during year-ago period.Handsome Net Profit growth of 93.22% reported above the corresponding previous quarter figure of Rs. 461.49 millions to Rs. 238.84 millions.Operating Profit saw a handsome growth to 672.35 millions from 342.19 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1661.02 1400.95 18.56 3267.28 2721.16 20.07 5703.70 4609.38 23.74
Other Income 25.18 24.67 2.07 47.42 53.85 -11.94 106.35 94.89 12.08
PBIDT 672.35 342.19 96.48 1320.01 816.28 61.71 1836.11 1383.87 32.68
Interest 4.27 4.60 -7.17 7.62 12.76 -40.28 21.10 30.84 -31.58
PBDT 668.08 337.59 97.90 1312.39 803.52 63.33 1815.01 1353.03 34.14
Depreciation 47.44 39.81 19.17 94.00 79.36 18.45 158.11 118.15 33.82
PBT 620.64 297.78 108.42 1218.39 724.16 68.25 1656.90 1234.88 34.17
TAX 159.15 58.94 170.02 310.46 200.20 55.07 465.76 336.30 38.50
Deferred Tax 4.69 -26.44 -117.74 9.33 15.19 -38.58 94.76 29.49 221.33
PAT 461.49 238.84 93.22 907.93 523.96 73.28 1191.14 898.58 32.56
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 40.48 24.43 65.72 40.40 30.00 34.68 32.19 30.02 7.22

Supriya Lifescience Share Price

728.65 -36.10 (-4.72%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.